Belite Bio, Inc. (NASDAQ: BLTE), (“Belite Bio®” or the “Company”), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal ...

Alzheimer’s, Parkinson’s, Macular Degeneration, & MS Share a Common Thread. Groundbreaking Research May Halt Disease Progression for Thousands of Patients I have stabilized patients with these ...

Satellos Bioscience Inc. (NASDAQ: MSLE, TSX: MSCL) (“Satellos” or the “Company”), a clinical-stage biotechnology company developing life-improving medicines to treat degenerative muscle diseases, ...

Please provide your email address to receive an email when new articles are posted on . Clinical gait analysis may objectively measure preoperative disability associated with lumbar degenerative ...

Two leading retinal specialists break down MCO-010's 3-year efficacy and safety data, the significance of contralateral eye findings, and how this gene-agnostic optogenetic approach could fill a ...

Degenerative joint diseases like osteoarthritis and intervertebral disk degeneration are conditions that affect millions of people worldwide, leading to pain and reduced mobility. These diseases ...

Although 67% of participants treated with SB-01 achieved the primary endpoint at 6 months, the difference when compared with sham treatment was not statistically significant. Topeline data were ...

Dry age-related macular degeneration (AMD) management is currently based on regular follow-up for early detection of choroidal neovascularization (CNV), addressing the risk factors and prescribing ...

A laser treatment for this common eye disease will start clinical trials in Finland next spring ––researchers hope it could be available to sufferers in as little as three years Around a third of ...

RA was tied to an increased risk of aortic stenosis, aortic regurgitation, and mitral regurgitation, independent of other cardiovascular risk factors. Women and younger patients with RA face a higher ...